PI
Pieris Pharma
PIRS·NASDAQBoston MAFounded 201260 employees
Micro CapbiotechPublicRespiratoryOncology
Platform: Anticalin
Market Cap
$0.05B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (PIRS)
Loading PIRS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Miriderotide | PIR-834 | Phase 1/2 | 1 | GPRC5D | FabryProstate Ca | ||
| Zanutuximab | PIR-4762 | Phase 1 | 2 | TIM-3 | Cervical Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)